Exploring computational lead optimisation with affinity constants obtained by surface plasmon resonance for the interaction of PorA epitope peptides with antibody against Neisseria meningitidis.

LUDI is a program used for de novo structure-based design of ligands and can predict binding of ligands quantitatively using a scoring function. Here we evaluate LUDI in a lead optimisation study with ligands for the antibody MN12H2, that has been raised against outer membrane protein PorA epitope P1.16 of Neisseria meningitidis. The ligands were synthetic peptides that are derived from the smallest binding epitope (182)DTNNN(186). LUDI's fragment building rules are used for the proposal of new peptide-ligands for MN12H2 and were focused on replacements of Asp(186) in the epitope. Accordingly, a series of peptides was synthesised with isosteric mutations. The interaction of the peptides with MN12H2 was analysed with a surface plasmon resonance competition assay yielding equilibrium binding constants in solution (K(S)). The binding affinity seems to be largely determined by entropy, and the side chain of Asn(186) is sensitive for charge, inversion, hydrophobicity and size. Head-to-tail cyclisation of the peptide in a nine-amino-acid ring gives little reduction in affinity. It is concluded that the scoring function of LUDI does not help in optimisation of the peptide lead for MN12H2 binding. Other more elaborate molecular mechanics calculations show similar results. This implies that our current knowledge of molecular recognition is insufficient for explaining a case of peptide-protein binding, where the design process requires subtle changes in structure (from lead finding to lead optimisation).

[1]  P. Schuck,et al.  Kinetics of ligand binding to receptor immobilized in a polymer matrix, as detected with an evanescent wave biosensor. I. A computer simulation of the influence of mass transport. , 1996, Biophysical journal.

[2]  J. Ladbury.  Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. , 1996, Chemistry & biology.

[3]  Hans-Joachim Böhm,et al.  LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads , 1992, J. Comput. Aided Mol. Des..

[4]  P. Gros,et al.  Bactericidal Antibody Recognition of Meningococcal PorA by Induced Fit , 1999, The Journal of Biological Chemistry.

[5]  L D Ward,et al.  Use of a biosensor with surface plasmon resonance detection for the determination of binding constants: measurement of interleukin-6 binding to the soluble interleukin-6 receptor. , 1995, Biochemistry.

[6]  P. Gros,et al.  Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: Crystal structure of a Fab fragment in complex with a fluorescein‐conjugated peptide , 1997, Proteins.

[7]  L. Nieba,et al.  Competition BIAcore for measuring true affinities: large differences from values determined from binding kinetics. , 1996, Analytical biochemistry.

[8]  D G Myszka,et al.  Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. , 1997, Methods in enzymology.

[9]  Elaine C. Meng,et al.  Evaluating docked complexes with the HINT exponential function and empirical atomic hydrophobicities , 1994, J. Comput. Aided Mol. Des..

[10]  Hans-Joachim Böhm,et al.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure , 1994, J. Comput. Aided Mol. Des..

[11]  M. Fischer,et al.  Kinetic analysis of the mass transport limited interaction between the tyrosine kinase lck SH2 domain and a phosphorylated peptide studied by a new cuvette-based surface plasmon resonance instrument. , 2000, Analytical biochemistry.

[12]  Rich,et al.  Implementing surface plasmon resonance biosensors in drug discovery. , 2000, Pharmaceutical science & technology today.

[13]  H. Valkenburg,et al.  Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  E C Nice,et al.  Analysis of the interaction between a synthetic peptide of influenza virus hemagglutinin and monoclonal antibodies using an optical biosensor. , 1996, Molecular immunology.

[15]  F. Stevens,et al.  Modification of an ELISA-based procedure for affinity determination: correction necessary for use with bivalent antibody. , 1987, Molecular immunology.

[16]  P. Schuck,et al.  Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules. , 1997, Annual review of biophysics and biomolecular structure.

[17]  P. A. van der Ley,et al.  Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine , 1996, Infection and immunity.

[18]  M. Virji,et al.  Topology of outer membrane porins in pathogenic Neisseria spp , 1991, Infection and immunity.

[19]  M. Malmqvist,et al.  Surface plasmon resonance for detection and measurement of antibody-antigen affinity and kinetics. , 1993, Current opinion in immunology.

[20]  A. Minton,et al.  Kinetic analysis of biosensor data: elementary tests for self-consistency. , 1996, Trends in biochemical sciences.

[21]  Scoring peptide(mimetic)-protein interactions , 1999 .

[22]  R. Karlsson,et al.  Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. , 1991, Journal of immunological methods.

[23]  Glen Eugene Kellogg,et al.  HINT: A new method of empirical hydrophobic field calculation for CoMFA , 1991, J. Comput. Aided Mol. Des..

[24]  D. Crommelin,et al.  On the interaction between a bactericidal antibody and a PorA epitope of Neisseria meningitidis in outer membrane vesicles: a competitive fluorescence polarization immunoassay. , 1997, Analytical biochemistry.

[25]  Hans-Joachim Böhm,et al.  The computer program LUDI: A new method for the de novo design of enzyme inhibitors , 1992, J. Comput. Aided Mol. Des..

[26]  S. Jakes,et al.  Determination of receptor-ligand kinetic and equilibrium binding constants using surface plasmon resonance: application to the lck SH2 domain and phosphotyrosyl peptides. , 1995, Journal of medicinal chemistry.

[27]  A. Szabó,et al.  Surface plasmon resonance and its use in biomolecular interaction analysis (BIA). , 1995, Current opinion in structural biology.

[28]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[29]  E. C. Beuvery,et al.  Preparation of clinical grade monoclonal antibodies from serum-containing cell culture supernatants. , 1991, JIM - Journal of Immunological Methods.

[30]  P. Hoogerhout,et al.  Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis , 1995, Infection and immunity.

[31]  C. Sander,et al.  Positioning hydrogen atoms by optimizing hydrogen‐bond networks in protein structures , 1996, Proteins.